Following CMS’s preliminary decision to limit the coverage of Biogen’s Alzehimer’s disease treatment Aduhelm, advocates are calling on the agency to broaden its coverage or risk the future of similar drugs, according to a Jan. 17 Politico report.
Two groups representing payers — America’s Health Insurance Plans and the Blue Cross Blue Shield Association — filed amicus briefs supporting HHS against a lawsuit challenging parts of the No Surprises Act.
Sartell, Minn.-based Center for Pain Management is challenging Blue Cross and Blue Shield of Minnesota’s decision to terminate its network contract, according to the St. Cloud Times.
More than 30 lawmakers penned a letter to CMS Administrator Chiquita Brooks-LaSure Jan. 18 asking her to reevaluate the proposed 14.5 percent increase to Medicare Part B premiums in 2022.
UnitedHealth Group will release its fourth quarter earnings report on Jan. 19, and the company is positioned to maintain the momentum it saw in the third quarter of 2021.
From trailblazing both stakeholder commitment and remote work to closing the books on a pair of lawsuits, here are seven recent stories on UnitedHealth Group, as reported by Becker’s Hospital Review:
Ethan Berke, MD, UnitedHealth Group chief public health officer, said any COVID-19 strategy should follow three steps: take a deep breath, step back and follow the science.